| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |